Cited by 77SARS-CoV-2 and COVID-19 ResearchT-cell and B-cell ImmunologyCOVID-19 Clinical Research Studies

T cells in COVID-19 — united in diversity

Open access
Swadling, Leo, Maini, Mala K.·2020·Nature Immunology

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41590-020-0798-y

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The shared target genes and pathways in corresponding cells were previously shown related to death from COVID-19.

    “The shared target genes and pathways in corresponding cells were previously shown related to death from COVID-1957–60.”
  • Neutrophil, NK cell, T cell, and monocyte play an important role in COVID-19-related death.

    “The population of neutrophil, NK cell, T cell, and monocyte increased in deceased severe COVID patients compared to the cured ones, suggesting the important role of these four types of cells in COVID-19-related death57–60 (Fig. 6b).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Swadling, L., & Maini, M. K.
Affiliations
University College London (GB)
Corresponding author
Maini, Mala K.
Venue
Nature Immunology
Published
2020-09-07
Volume
21
Issue
11
Pages
1307-1308
ISSN
  • 1529-2908 (ISSN-L)
  • 1529-2916
OpenAlex
W3083285583
Cited by
77
References
13
Citations by year
2026: 2 · 2025: 1 · 2024: 8 · 2023: 17 · 2022: 20 · 2021: 25 · 2020: 4
FWCI
2.17
Type
journal article
Language
en
Open access
Locations
  • Nature Immunology (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
Funders
Wellcome Trust
Topics
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Keywords
COVID-19 pandemic, SARS-CoV-2, T cell response, CD4+ T cells, CD8+ T cells, T cell receptor repertoire, epitope mapping, antibody response, disease severity
MeSH terms
Betacoronavirus, COVID-19, SARS-CoV-2, United Kingdom, Humans, Pneumonia, Viral, CD4-Positive T-Lymphocytes, Coronavirus Infections, CD8-Positive T-Lymphocytes, Severe acute respiratory syndrome-related coronavirus, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review